4-Chloromethyl-2-(3,4,5-trimethoxyphenyl) pyridine → HCID 22557903, compound
Reaction equation
[CH2:1]([NH:4][CH:5]1[CH2:10][CH2:9][N:8]([CH2:11][C:12]2[CH:17]=[CH:16][N:15]=[C:14]([C:18]3[CH:23]=[C:22]([O:24][CH3:25])[C:21]([O:26][CH3:27])=[C:20]([O:28][CH3:29])[CH:19]=3)[CH:13]=2)[CH2:7][CH2:6]1)[C:2]#[CH:3].[Cl:30][CH2:31][C:32]1[CH:37]=[CH:36][N:35]=[C:34]([C:38]2[CH:43]=[C:42]([O:44][CH3:45])[C:41]([O:46][CH3:47])=[C:40]([O:48][CH3:49])[CH:39]=2)[CH:33]=1>>[ClH:30].[ClH:30].[ClH:30].[ClH:30].[CH2:1]([N:4]([CH:5]1[CH2:6][CH2:7][N:8]([CH2:11][C:12]2[CH:17]=[CH:16][N:15]=[C:14]([C:18]3[CH:19]=[C:20]([O:28][CH3:29])[C:21]([O:26][CH3:27])=[C:22]([O:24][CH3:25])[CH:23]=3)[CH:13]=2)[CH2:9][CH2:10]1)[CH2:31][C:32]1[CH:37]=[CH:36][N:35]=[C:34]([C:38]2[CH:43]=[C:42]([O:44][CH3:45])[C:41]([O:46][CH3:47])=[C:40]([O:48][CH3:49])[CH:39]=2)[CH:33]=1)[C:2]#[CH:3]Participants
3
Procedure
4-Propargylamino-1-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]piperidine (227 mg) and 4-chloromethyl-2-(3,4,5-trimethoxyphenyl)pyridine (226 mg) were condensed in the same manner as described in Example 9. The title compound was obtained as yellow powder after converting a free base to a tetrahydrochloride.
Workup
- customcondensed in the same manner
Sources & evidence
- ORD record
- ord-2f7768c2eec64023b94a5fbe7d4b7f3a
- Source dataset
- uspto-grants-2005_03
- Patent number
- US06867221B2
Reaction notes
Loading…